Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$0.18.

  • Maravai Lifesciences Holdings' EPS (Basic) rose 7352.94% to -$0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.84, marking a year-over-year increase of 4878.05%. This contributed to the annual value of -$1.88 for FY2024, which is 10917.79% down from last year.
  • According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' EPS (Basic) is -$0.18, which was up 7352.94% from -$0.27 recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' EPS (Basic) registered a high of $0.54 during Q2 2022, and its lowest value of -$0.8 during Q4 2023.
  • For the 5-year period, Maravai Lifesciences Holdings' EPS (Basic) averaged around $0.02, with its median value being -$0.05 (2023).
  • Per our database at Business Quant, Maravai Lifesciences Holdings' EPS (Basic) soared by 764781.23% in 2021 and then plummeted by 126000.0% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' EPS (Basic) (Quarter) stood at $0.43 in 2021, then plummeted by 34.88% to $0.28 in 2022, then tumbled by 385.71% to -$0.8 in 2023, then skyrocketed by 58.24% to -$0.33 in 2024, then surged by 46.12% to -$0.18 in 2025.
  • Its last three reported values are -$0.18 in Q3 2025, -$0.27 for Q2 2025, and -$0.37 during Q1 2025.